CEIN
CAMBER ENERGY, INC.
$0.0300
0.00%
No data for this timeframe.
Vol
Inst. Holders1 funds
Inst. Value$8.00
SEC Reports1
Recent Activity
Jun 9, 2026
Event
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
WARNING: FETAL TOXICITY When pregnancy is detected, discontinue losartan potassium and hydrochloroth
May 19, 2026
earnings_calendar
CEIN Q1 2026 Earnings Scheduled — 2026-05-19
Apr 13, 2026
SEC
Camber Energy provided an update on the continued validation, field deployment, and technical advancements of its patent
8-K — Impact 5/10
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BARCLAYS PLC | $8.00 | — |
1 institutional holders with $8.00 total value (360 shares) as of 2025-Q3. Top holders: BARCLAYS.
Top Institutional Holders — 2025-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BARCLAYS PLC | 360 | $8.00 | 100.0% | — |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 5.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 9, 2026
FDA
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
WARNING: FETAL TOXICITY When pregnancy is detected, discontinue losartan potassium and hydrochlorothiazide as soon as possible. Drugs that act directl
May 19, 2026
earnings_calendar
CEIN Q1 2026 Earnings Scheduled — 2026-05-19
May 12, 2026
FDA
capecitabine
WARNING: SERIOUS ADVERSE REACTIONS OR DEATH IN PATIENTS WITH COMPLETE DPD DEFICIENCY and INCREASED RISK OF BLEEDING WITH CONCOMITANT USE OF VITAMIN K
May 11, 2026
earnings_calendar
CEIN Q4 2025 Earnings Scheduled — 2026-05-11
Apr 29, 2026
FDA
PAROXETINE HYDROCHLORIDE
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients i
Apr 23, 2026
FDA
Acetaminophen
WARNING: RISK OF MEDICATION ERRORS AND HEPATOTOXICITY Take care when prescribing, preparing, and administering acetaminophen injection to avoid dosing
Apr 22, 2026
FDA
BUPROPION HYDROCHLORIDE
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS SUICIDALITY AND ANTIDEPRESSANT DRUGS Antidepressants increased the risk of suicidal thoughts and behavior in